Advertisement
Product › Details
cancer drug
Next higher product group | pharmaceutical | |
Status | 1998-01-01 sales existent | |
Record changed: 2024-08-31 |
Advertisement
More documents for cancer drug
- [1] Edinburgh Molecular Imaging Ltd.. (12/17/19). "Press Release: Edinburgh Molecular Imaging Closes Financing". Edinburgh....
- [2] Agilent Technologies Inc.. (10/2/19). "Press Release: Agilent Receives Approval for First PD-L1 Companion Diagnostic in China". Santa Clara, CA....
- [3] Agilent Technologies Inc.. (6/11/19). "Press Release: Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)". Santa Clara, CA....
- [4] Fluidigm Corporation. (5/2/19). "Press Release: Leading Cancer Center in Japan Selects Hyperion Imaging System to Expand Immuno-Oncology Research Studies in Colorectal Cancer". South San Francisco, CA....
- [5] Merck KGaA. (4/26/19). "Press Release: Merck Presents Plans for Future Growth to Shareholders. 24th Annual General Meeting in Frankfurt am Main". Frankfurt a. M.....
- [6] Agilent Technologies Inc.. (4/12/19). "Press Release: Agilent Presents Thought Leader Award to Professor Antoni Ribas". Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top